Related Experiment Video
Updated: Feb 26, 2026
Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery
Published on: July 5, 2021
Mucormycosis of the Frontal Sinus: A Rare Case Report and Review
Nanda Kishore Sahoo1, Vishal Kulkarni2, Amit K Bhandari2
1Department of Oral and Maxillofacial Surgery, CMDC (WC), Chandimandir, Haryana, India.
Abstract:
Mucormycosis of the frontal sinus are rarely seen in day to day clinical practice. Although this fungus is commonly found in the environment, the disease is usually prevented by the immune system and is hence rare. Well-recognized risk factors for the disease include diabetes mellitus, leukemia, aplastic anemia, myelodysplastic syndrome, blood dyscrasias, and immunosuppressive therapy in organ transplantation, renal disease, sepsis, and severe burns. The disease is primarily found in those who are immunocompromised, but it may also manifest in immuno competent persons. Current therapy for the invasive disease includes early surgical debridement, antifungal therapy management of underlying predisposing factors. Early recognition of the disease and treating the underlying cause of mucormycosis, such as diabetes, are key to improving outcomes. The antifungal treatment of choice for mucormycosis is amphotericin B, although very high doses are required because of the relative resistance of the fungus to the drug. Here, we present a case of rhinocerebral mucormycosis of frontal sinus in a diabetic patient, who was managed by systemic antifungals, surgical debridement, and obliteration procedures.
Insights
Mucormycosis of the frontal sinus is a rare fungal infection, often affecting immunocompromised individuals. Early diagnosis and treatment, including antifungals and surgery, are crucial for managing this serious condition, especially in diabetic patients.
Area of Science:
- Mycology
- Infectious Diseases
- Otolaryngology
Background:
- Mucormycosis, a rare but severe fungal infection, typically affects immunocompromised individuals.
- Risk factors include diabetes mellitus, hematologic malignancies, and immunosuppressive therapies.
- Frontal sinus mucormycosis presents a diagnostic and therapeutic challenge due to its rarity.
Observation:
- This case report details a patient with frontal sinus mucormycosis, a rare clinical presentation.
- The patient had a predisposing condition of diabetes mellitus.
- Rhinocerebral mucormycosis involving the frontal sinus was diagnosed.
Findings:
- The patient was managed with a combination of systemic antifungal therapy, specifically amphotericin B, and surgical debridement.
- Obliteration procedures were also employed as part of the treatment strategy.
- Successful management highlights the importance of aggressive therapeutic interventions.
Implications:
- Early recognition and prompt treatment, including surgical intervention and appropriate antifungal agents, are vital for favorable outcomes in frontal sinus mucormycosis.
- Managing underlying conditions, such as diabetes mellitus, is a critical component of successful treatment.
- This case underscores the need for heightened clinical suspicion for mucormycosis in at-risk populations presenting with sinonasal symptoms.
